1. Cancer expert attacks research paper.
- Author
-
White, Caroline
- Subjects
- *
CANCER research , *CANCER patients , *CANCER treatment , *PHARMACEUTICAL industry , *DRUG approval - Abstract
This article looks at the Karolinska 2 report which compared cancer survival rates in 25 countries and found that access to cancer drugs affected survival concluding that the licensing process should be speeded up with equitable access to all. British epidemiologist Michel Coleman who heads Cancer Research UK says the study is flawed and the conclusion questionable. Coleman claims that estimates rather than actual survival rates were used and the benefits from access to drugs information was skewed. Further, he suggested that study sponsor, Roche Pharmaceuticals, had input into the conclusion. The charges are denied by Roche and by the authors of the study.
- Published
- 2007
- Full Text
- View/download PDF